Related Experiment Video
Updated: Jun 5, 2026
08:49
Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
B-type natriuretic peptide levels and continuous-flow left ventricular assist devices
Basar Sareyyupoglu1, Barry A Boilson, Lucian A Durham
1Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota 55205, USA.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|January 20, 2011
Summary
Postoperative B-type natriuretic peptide (BNP) levels reflect left ventricular assist device (LVAD) support. Higher pump speeds correlate with lower BNP, indicating improved hemodynamic support and effective LVAD function.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Device Technology
Background:
- Left ventricular assist devices (LVADs) are crucial for managing advanced heart failure.
- Assessing the efficacy of LVADs, particularly continuous-flow models, requires reliable physiological markers.
- B-type natriuretic peptide (BNP) is a known biomarker for cardiac strain.
Purpose of the Study:
- To investigate the relationship between postoperative B-type natriuretic peptide (BNP) levels and the hemodynamic support provided by continuous-flow left ventricular assist devices (LVADs) at varying pump speeds (RPM).
- To determine if serial BNP measurements can serve as a useful tool for managing patients with LVAD support.
Main Methods:
- Prospective evaluation of 20 LVAD patients (Jarvik 2000 and HeartMate II) with serial postoperative BNP measurements at different device RPM settings.
- Correlation analysis between LVAD pump speed (RPM) and corresponding changes in BNP levels.
- Analysis of patient outcomes, including duration of support (lifelong vs. bridge to transplantation) and device-related complications.
Main Results:
- Postoperative BNP levels significantly decreased upon initiation of LVAD support.
- A significant inverse correlation was observed between BNP levels and the degree of hemodynamic support at various HeartMate II RPM settings (p < 0.001).
- BNP levels decreased significantly within 2 days following an increase in LVAD RPM.
Conclusions:
- Postoperative BNP levels are a reliable indicator of the hemodynamic support efficacy provided by continuous-flow LVADs.
- Effective LVAD support, reflected by increased RPM, leads to a marked reduction in BNP levels.
- Monitoring serial BNP levels can aid in the clinical management and optimization of LVAD therapy.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...